Nanobiotix S.A. (EPA:NANO)
28.34
-0.02 (-0.07%)
Apr 28, 2026, 5:35 PM CET
Nanobiotix Employees
Nanobiotix had 108 employees as of December 31, 2024. The number of employees increased by 6 or 5.88% compared to the previous year.
Employees
108
Change (1Y)
6
Growth (1Y)
5.88%
Revenue / Employee
€316,437
Profits / Employee
€232,631
Market Cap
1.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| DBV Technologies | 117 |
| Inventiva | 77 |
| MedinCell | 145 |
| Valneva SE | 674 |
| Genfit | 188 |
| ABIVAX Société Anonyme | 69 |
| Cellectis | 229 |
| Transgene | 145 |
Nanobiotix News
- 8 days ago - Nanobiotix Announces Positive Preclinical Data For Nanoprimer In LNP-DNA Delivery - Nasdaq
- 8 days ago - Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - GlobeNewsWire
- 21 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 27 days ago - Nanobiotix Earnings Call Transcript: H2 2025 - Transcripts
- 27 days ago - Nanobiotix FY25 Net Loss Narrows; Expects Cash Runway Through Early 2028; Stock Down - Nasdaq
- 4 weeks ago - NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - GlobeNewsWire
- 4 weeks ago - Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga